Tamoxifen inhibits cell proliferation by impaired glucose metabolism in gallbladder cancer

Gallbladder cancer (GBC) is the leading malignancy of biliary system showing refractory chemoresistance to current first‐line drugs. Growing epidemiological evidences have established that the incidence of GBC exhibits significant gender predominance with females two‐threefold higher than males, sug...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Shuai, Wang, Hui, Chen, Wei, Zhan, Ming, Xu, Sunwang, Huang, Xince, Lin, Ruirong, Shen, Hui, Wang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6991689/
https://www.ncbi.nlm.nih.gov/pubmed/31782270
http://dx.doi.org/10.1111/jcmm.14851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6991689/
https://www.ncbi.nlm.nih.gov/pubmed/31782270
http://dx.doi.org/10.1111/jcmm.14851

Ejemplares similares